Covered recipient · General Payments record
MARC ALAN SILVER
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2019–2024
$93,494.73
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $78,000.00 | 12 |
| Food and Beverage | $255.70 | 4 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daxor Corporation | $78,000.00 | 12 |
| ABIOMED | $127.02 | 1 |
| Cardiac Dimensions, Inc. | $90.40 | 1 |
| Acerta Pharma LLC | $38.28 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $127.02 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142287305 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.97 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105468535 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.31 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105560444 | CMS |
| Cardiac Dimensions, Inc. | $90.40 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125991303 | CMS |
| Daxor Corporation | $6,500.00 | 01/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136816316 | CMS |
| Daxor Corporation | $6,500.00 | 02/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136816312 | CMS |
| Daxor Corporation | $6,500.00 | 03/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136816308 | CMS |
| Daxor Corporation | $6,500.00 | 04/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136816304 | CMS |
| Daxor Corporation | $6,500.00 | 05/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136816301 | CMS |
| Daxor Corporation | $6,500.00 | 06/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136816296 | CMS |
| Daxor Corporation | $6,500.00 | 07/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136816293 | CMS |
| Daxor Corporation | $6,500.00 | 08/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136816288 | CMS |
| Daxor Corporation | $6,500.00 | 09/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136816285 | CMS |
| Daxor Corporation | $6,500.00 | 10/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136816281 | CMS |
| Daxor Corporation | $6,500.00 | 11/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136816277 | CMS |
| Daxor Corporation | $6,500.00 | 12/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136816273 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.